1. Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol. 2000. 43:649–655.
Article
2. Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol. 2006. 118:214–219.
Article
3. Nomura T, Sandilands A, Akiyama M, Liao H, Evans AT, Sakai K, et al. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol. 2007. 119:434–440.
Article
4. Gupta J, Grube E, Ericksen MB, Stevenson MD, Lucky AW, Sheth AP, et al. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol. 2008. 121:725–730.
Article
5. Kim DW, Park JY, Na GY, Lee SJ, Lee WJ. Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis. Int J Dermatol. 2006. 45:698–701.
Article
6. Sung HC, Jung HD, Park KD, Lee WJ, Lee SJ, Kim DW. A quantitative culture study of Staphylococcus aureus in adolescent and adult patients with atopic dermatitis using the contact-plate sampling technique. Korean J Dermatol. 2007. 45:673–679.
7. Lebon A, Labout JA, Verbrugh HA, Jaddoe VW, Hofman A, van Wamel WJ, et al. Role of Staphylococcus aureus nasal colonization in atopic dermatitis in infants: the Generation R Study. Arch Pediatr Adolesc Med. 2009. 163:745–749.
8. Park YL, Kim HD, Kim KH, Kim MN, Kim JW, Ro YS, et al. Report from ADRG: a study on the diagnostic criteria of Korean atopic dermatitis. Korean J Dermatol. 2006. 44:659–663.
9. Roll A, Cozzio A, Fischer B, Schmid-Grendelmeier P. Microbial colonization and atopic dermatitis. Curr Opin Allergy Clin Immunol. 2004. 4:373–378.
Article
10. Breuer K, Kapp A, Werfel T. Bacterial infections and atopic dermatitis. Allergy. 2001. 56:1034–1041.
Article
11. Breuer K, HAussler S, Kapp A, Werfel T.
Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol. 2002. 147:55–61.
Article
12. Tomi NS, Kränke B, Aberer E. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. J Am Acad Dermatol. 2005. 53:67–72.
Article
13. Bunikowski R, Mielke ME, Skarabis H, Worm M, Anagnostopoulos I, Kolde G, et al. Evidence for a disease-promoting effect of
Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol. 2000. 105:814–819.
Article
14. Kim DW, Park JY, Park KD, Kim TH, Lee WJ, Lee SJ, et al. Are there predominant strains and toxins of
Staphylococcus aureus in atopic dermatitis patients? Genotypic characterization and toxin determination of
S. aureus isolated in adolescent and adult patients with atopic dermatitis. J Dermatol. 2009. 36:75–81.
Article
15. Yagi S, Wakaki N, Ikeda N, Takagi Y, Uchida H, Kato Y, et al. Presence of staphylococcal exfoliative toxin A in sera of patients with atopic dermatitis. Clin Exp Allergy. 2004. 34:984–993.
Article
16. Zouharova M, Rysanek D. Multiplex PCR and RPLA Identification of
Staphylococcus aureus enterotoxigenic strains from bulk tank milk. Zoonoses Public Health. 2008. 55:313–319.
Article
17. Yim YS, Park CW, Lee CH, Song WK. A study on the evaluation of the staphylococcal exotoxins and staphylococcal enterotoxin a-specific ige antibody in childhood atopic dermatitis. Korean J Dermatol. 2002. 40:607–615.
18. Leung DY, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest. 1993. 92:1374–1380.
Article